` 238120 (Aligned Genetics Inc) vs KOSPI 200 Comparison - Alpha Spread

A
238120
vs
K
KOSPI 200

Over the past 12 months, Aligned Genetics Inc has underperformed KOSPI 200, delivering a return of -20% compared to KOSPI 200's +116% growth.

Stocks Performance
238120 vs KOSPI 200

Loading...
238120
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
238120 vs KOSPI 200

Loading...
238120
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
238120 vs KOSPI 200

Loading...
238120
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Aligned Genetics Inc vs Peers

KOSPI 200
238120
TMO
DHR
603259
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Aligned Genetics Inc
Glance View

Aligned Genetics Inc appears to be a life-science company focused on genetics, meaning it works with DNA-based testing, analysis, or related lab services. Companies like this typically help customers identify genetic markers, study biological samples, or develop tools used in research and medical settings. Its main customers are usually hospitals, research labs, clinics, or other businesses that need genetic information to support diagnosis, research, or product development. The company would make money by selling tests, lab services, software, or specialized genetic products rather than by selling to everyday consumers. What makes this kind of business different is that it sits close to the scientific and medical side of healthcare. Instead of making a broad consumer product, it earns trust by handling complex biological data and turning it into something doctors, researchers, or drug developers can use.

Intrinsic Value
₩3 952.28
Undervaluation 32%
Intrinsic Value
Price ₩2 695
A
Back to Top